TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,701 | -3.5% | 1,532 | -2.0% | 0.00% | 0.0% |
| Q2 2023 | $24,571 | +29.4% | 1,564 | +35.8% | 0.00% | 0.0% |
| Q1 2023 | $18,985 | +532.8% | 1,152 | +473.1% | 0.00% | – |
| Q1 2022 | $3,000 | +200.0% | 201 | +99.0% | 0.00% | – |
| Q4 2021 | $1,000 | -97.5% | 101 | -95.7% | 0.00% | -100.0% |
| Q2 2021 | $40,000 | 0.0% | 2,372 | +7.8% | 0.01% | -16.7% |
| Q4 2020 | $40,000 | +2.6% | 2,200 | 0.0% | 0.01% | -14.3% |
| Q3 2020 | $39,000 | 0.0% | 2,200 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $39,000 | +18.2% | 2,200 | 0.0% | 0.01% | -12.5% |
| Q1 2020 | $33,000 | -23.3% | 2,200 | 0.0% | 0.01% | -33.3% |
| Q4 2019 | $43,000 | +13.2% | 2,200 | 0.0% | 0.01% | +9.1% |
| Q3 2019 | $38,000 | +81.0% | 2,200 | +83.3% | 0.01% | +57.1% |
| Q2 2019 | $21,000 | +5.0% | 1,200 | 0.0% | 0.01% | -12.5% |
| Q4 2018 | $20,000 | – | 1,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |